Tirzepatide is the generic name for Zepbound [1].
What is Tirzepatide Used For?
Tirzepatide is a medication used for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol [1]. It is administered as a once-weekly injection [1].
How Does Tirzepatide Work?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [1]. By activating these receptors, it helps to lower blood glucose levels and promote weight loss by affecting appetite and satiety [1].
Who Manufactures Zepbound?
Zepbound is manufactured by Eli Lilly and Company [1].
When Does Zepbound Patent Expire?
Information on specific patent expiry dates for Zepbound can be found on DrugPatentWatch.com [2]. Patent litigation and exclusivities can affect the availability of generic versions.
What Other Medications Are Similar to Tirzepatide?
Other GLP-1 receptor agonists used for weight management include semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda, Victoza) [3]. Tirzepatide's dual action on GIP and GLP-1 receptors differentiates it from single-receptor agonists.
What Clinical Data Supports Tirzepatide's Use?
Clinical trials for tirzepatide have demonstrated significant reductions in body weight in participants with obesity or overweight status [1]. For example, the SURMOUNT-1 trial showed that participants treated with tirzepatide achieved substantial weight loss compared to a placebo [1].
What Are the Potential Side Effects of Tirzepatide?
Common side effects associated with tirzepatide include nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite [1]. Serious side effects, though less common, can include pancreatitis, gallbladder problems, kidney problems, and certain types of thyroid tumors [1].
What Are the Risks Associated with Tirzepatide?
Individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use tirzepatide due to a potential increased risk of thyroid C-cell tumors [1]. It is also not recommended for patients with a history of pancreatitis [1].
Can Tirzepatide Be Used for Diabetes Management?
While tirzepatide is approved for weight management, its dual GIP and GLP-1 mechanism also makes it effective in managing blood glucose levels in adults with type 2 diabetes [4]. Mounjaro, also from Eli Lilly, contains tirzepatide and is approved for type 2 diabetes treatment [4].
How Much Does Tirzepatide Cost?
The cost of Zepbound can vary depending on insurance coverage and pharmacy. Information regarding pricing and potential savings programs is often available through the manufacturer's website or patient assistance programs.
---
Cited Sources:
1. Zepbound Official Website
2. DrugPatentWatch.com
3. National Institutes of Health - GLP-1 Receptor Agonists
4. Mounjaro Official Website